BioSpace News Archive

Biocodex is pleased to announce that on August 20th, 2018, the Food and Drug Administration (FDA) has approved DIACOMIT (stiripentol) for the treatment of seizures associated with Dravet syndrome (DS) in patients 2 years of age and older taking clobazam.

Novaremed AG announced today that it has successfully raised additional financing of CHF 6 million from existing shareholders and several new private investors.

The Foundation has awarded $149,000 in grants to fund quality of life research that can change the way people live with Parkinson’s.

Members of the management team will also be attending the B. Riley FBR Healthcare Conference where it will be hosting investor meetings.

PerkinElmer, Inc. today announced that the Company will present at the 16th annual Morgan Stanley Global Healthcare Conference on Friday, September 14, 2018 at 11:40 a.m. ET at the Grand Hyatt New York in New York City.

Total Revenues of $209.6M, up 25% Year-over-year

With the acquisition, PTC adds GT-AADC, an adeno-associated virus (AAV) gene therapy that treats Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency.

Revenues Increased to RMB233.8 Million ($35.3 Million)

Reliant Rehabilitation Holdings, Inc. has reached a civil settlement with the U.S. government to resolve an investigation and civil litigation related to the Company’s discontinued Reliant Medical Management program (the RMM Program) at certain Skilled Nursing Facilities (SNFs).

CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, launches a self-service capability and a customer enablement program to empower CROs and Sponsors to manage all aspects of electronic informed consent using a licensed, cloud-based version of the industry’s first electronic informed consent platform with fully embedded design tool.